619
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Nintendo WiiTMversus Xbox KinectTM for functional locomotion in people with Parkinson’s disease: a systematic review and network meta-analysis

ORCID Icon, , , , &
Pages 331-336 | Received 15 Feb 2020, Accepted 08 May 2020, Published online: 01 Jun 2020
 

Abstract

Purpose

To investigate the effectiveness of commercial exergames treatments on people with Parkinson’s disease (PD), a systematic review and network meta-analysis (NMA) of randomised controlled trials (RCT) was performed to evaluate functional locomotion effects in patients with PD.

Methods

A comprehensive search on PubMed, Embase, Cochrane Controlled Trials Register, the Cochrane, and other databases without language restrictions was conducted. References and reviews were cross-checked for possible studies. RCTs from 2012 were included. Seven studies with 236 participants were included in the NMA that used a random-effect Frequentist model to investigate the standard mean difference of pooled effect sizes change in functional locomotion between baseline and delayed retention tests on six comparisons.

Results

The direct comparisons Kinect: Control (n = 4), Wii: Control (n = 5) and the indirect-network comparison Kinect: Wii (n = 1) determine that Nintendo Wii™ may be the best choice in functional locomotion improvements.

Conclusions

These network meta-analytic findings show that Kinect and Wii show immediate positive effects on functional locomotion in people with PD. Compared with Kinect RCTs, Wii may be considered the best therapy for providing functional recovery in PD.

    Implications for rehabilitation

  • Exergames rehabilitation reveals intervention benefits for functional locomotion in people with PD.

  • In patients with cognitive disorders, Wii’s platform can be considered a visual reference and a cue to facilitate patients with freezing.

  • Nintendo Wii seems to be a better device for locomotion rehabilitation in people with PD than Xbox Kinect.

Disclosure statement

The material was not presented at an AAPM&R Annual Assembly and do not have any funding source. The authors declare that they have no financial interest or advantage deriving from the direct applications of my research.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.